Source: Annual Congress 2003 - Pulmonary hypertension
Disease area: Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
N. Tanabe, A. Kimura, S. Amano, O. Okada, Y. Kasahara, Y. Takiguchi, K. Tatsumi, M. Takahashi, H. Shibata, M. Yasunami, T. Kuriyama (Chiba, Tokyo, Japan). Association of clinical characteristics with HLA in chronic thromboembolic pulmonary hypertension. Eur Respir J 2003; 22: Suppl. 45, 2931

Member's Comments

No comment yet.

Related content which might interest you: Association of clinical features with HLA in chronic pulmonary thromboembolism Source: Eur Respir J 2005; 25: 131-138 Year: 2005 Determinants of diagnostic delay in chronic thromboembolic pulmonary hypertension: results from the European CTEPH Registry Source: Eur Respir J, 52 (6) 1801687; 10.1183/13993003.01687-2018 Year: 2018 Genetic diagnostics in patients with chronic thromboembolic pulmonary hypertension Source: International Congress 2019 – Novel methods, diagnostics and biomarkers in chronic lung diseases Year: 2019 Characteristics of chronic thromboembolic pulmonary hypertension in Ireland Source: Virtual Congress 2021 – Non-pulmonary arterial hypertension pulmonary hypertension Year: 2021 Comparison of clinical characteristics in patients with pulmonary arterial hypertension and inoperable chronic thromboembolic pulmonary hypertension Source: Annual Congress 2008 - Pulmonary venous thromboembolic disease Year: 2008 Clinical characteristics and prognosis in patients with chronic thromboembolic pulmonary hypertension and a psychiatric disorder Source: International Congress 2018 – Clinical aspects of pulmonary hypertension Year: 2018 Comprehensive analysis of inflammatory markers in chronic thromboembolic pulmonary hypertension patients Source: Eur Respir J 2014; 44: 951-962 Year: 2014 Chronic thromboembolic pulmonary hypertension and associated medical conditions Source: Annual Congress 2008 - Acute and chronic pulmonary thromboembolic disease Year: 2008 Risk factors for chronic thromboembolic pulmonary hypertension Source: Eur Respir Rev 2012; 21: 27-31 Year: 2012 ERS statement on chronic thromboembolic pulmonary hypertension Source: ERS webinar 2021: ERS statement on chronic thromboembolic pulmonary hypertension Year: 2021 Clinical presentation and outcomes of venous thrombo-embolic diseases in chronic obstructive pulmonary diseases. Findings from the RIETE Registry Source: Annual Congress 2010 - Pulmonary venous thromboembolic disease and other pulmonary vascular disorders Year: 2010 Diagnosis of chronic thromboembolic pulmonary hypertension Source: Eur Respir Rev 2017; 26: 160108 Year: 2017 First international registry on chronic thromboembolic pulmonary hypertension (CTEPH) Source: Annual Congress 2008 - Pulmonary venous thromboembolic disease Year: 2008 Risk assessment in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension Source: Eur Respir J, 53 (6) 1802004; 10.1183/13993003.02004-2018 Year: 2019 Prognostic and aetiological factors in chronic thromboembolic pulmonary hypertension Source: Eur Respir J 2009; 33: 332-338 Year: 2009 Pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension: pathophysiology Source: Eur Respir Rev 2009; 19: 59-63 Year: 2010 Analysis of mortality risk factors in a population with pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension Source: Annual Congress 2010 - Pulmonary hypertension Year: 2010 Chronic thromboembolic pulmonary hypertension Source: International Congress 2015 – ME5 Chronic thromboembolic pulmonary hypertension Year: 2015 Chronic thromboembolic pulmonary hypertension Source: International Congress 2018 – State of the art session: Pulmonary vascular diseases Year: 2018